Phio Pharmaceuticals (PHIO) Revenue (2012 - 2019)

Phio Pharmaceuticals (PHIO) has reported Revenue for 8 consecutive years, with $21000.0 the latest figure, recorded in Q1 2019.

• For the quarter ending Q1 2019, Revenue fell 8.7% year-over-year to $21000.0; the trailing twelve-month figure through Dec 2019 stood at $21000.0 (down 84.78% YoY), and the FY2019 full-year result was $21000.0, down 84.78% from the prior year.
• Revenue eased to $21000.0 in Q1 2019 per PHIO's latest filing, from $57000.0 in the prior quarter.
• Across five years, Revenue topped out at $58000.0 in Q2 2018 and bottomed at $9000.0 in Q2 2016.
• Historically, Revenue has averaged $28375.0 across 5 years, with a median of $22000.0 in 2018.
• The sharpest annual moves came in 2015 and 2016: Revenue increased 17.24% in 2015, then slumped 70.59% in 2016.
• Over 5 years, Revenue stood at $34000.0 in 2015, then tumbled by 73.53% to $9000.0 in 2016, then surged by 66.67% to $15000.0 in 2017, then jumped by 280.0% to $57000.0 in 2018, then tumbled by 63.16% to $21000.0 in 2019.
• According to Business Quant data, Revenue over the past three periods registered $21000.0, $57000.0, and $58000.0 for Q1 2019, Q3 2018, and Q2 2018 respectively.